Alpha Omega Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.53M | Sell |
26,593
-200
| -0.7% | -$11.5K | 0.23% | 104 |
|
|
2026
Q1 | $1.62M | Sell |
26,793
-98
| -0.4% | -$5.71K | 0.26% | 96 |
|
|
2025
Q4 | $1.45M | Sell |
26,891
-674
| -2% | -$32.4K | 0.24% | 102 |
|
|
2025
Q3 | $1.24M | Sell |
27,565
-2,375
| -8% | -$111K | 0.21% | 108 |
|
|
2025
Q2 | $1.39M | Sell |
29,940
-190
| -0.6% | -$9.33K | 0.25% | 101 |
|
|
2025
Q1 | $1.84M | Buy |
30,130
+439
| +1% | +$25.6K | 0.35% | 82 |
|
|
2024
Q4 | $1.68M | Buy |
29,691
+257
| +0.9% | +$14.4K | 0.32% | 88 |
|
|
2024
Q3 | $1.52M | Sell |
29,434
-1,664
| -5% | -$78.1K | 0.28% | 95 |
|
|
2024
Q2 | $1.29M | Sell |
31,098
-5,873
| -16% | -$263K | 0.25% | 98 |
|
|
2024
Q1 | $2M | Sell |
36,971
-674
| -2% | -$34.3K | 0.37% | 83 |
|
|
2023
Q4 | $1.93M | Sell |
37,645
-300
| -0.8% | -$15.7K | 0.32% | 84 |
|
|
2023
Q3 | $2.2M | Sell |
37,945
-2,619
| -6% | -$160K | 0.38% | 75 |
|
|
2023
Q2 | $2.59M | Sell |
40,564
-471
| -1% | -$31.6K | 0.44% | 63 |
|
|
2023
Q1 | $2.84M | Sell |
41,035
-476
| -1% | -$33.6K | 0.49% | 57 |
|
|
2022
Q4 | $2.99M | Sell |
41,511
-600
| -1% | -$45.2K | 0.53% | 56 |
|
|
2022
Q3 | $2.99M | Sell |
42,111
-717
| -2% | -$52K | 0.57% | 56 |
|
|
2022
Q2 | $3.3M | Sell |
42,828
-939
| -2% | -$71.5K | 0.59% | 52 |
|
|
2022
Q1 | $3.2M | Sell |
43,767
-443
| -1% | -$29.7K | 0.51% | 58 |
|
|
2021
Q4 | $2.86M | Sell |
44,210
-447
| -1% | -$26.2K | 0.44% | 69 |
|
|
2021
Q3 | $2.64M | Buy |
44,657
+645
| +1% | +$42.5K | 0.43% | 71 |
|
|
2021
Q2 | $2.94M | Sell |
44,012
-499
| -1% | -$32.5K | 0.48% | 65 |
|
|
2021
Q1 | $2.81M | Sell |
44,511
-315
| -0.7% | -$19.6K | 0.49% | 62 |
|
|
2020
Q4 | $2.78M | Sell |
44,826
-912
| -2% | -$56.1K | 0.47% | 59 |
|
|
2020
Q3 | $2.76M | Sell |
45,738
-50
| -0.1% | -$3.01K | 0.39% | 52 |
|
|
2020
Q2 | $2.69M | Sell |
45,788
-355
| -0.8% | -$21.2K | 0.41% | 51 |
|
|
2020
Q1 | $2.57M | Sell |
46,143
-103
| -0.2% | -$6.3K | 0.47% | 44 |
|
|
2019
Q4 | $2.97M | Buy |
46,246
+1,217
| +3% | +$69.7K | 0.48% | 53 |
|
|
2019
Q3 | $2.61M | Buy |
45,029
+31,680
| +237% | +$1.49M | 0.42% | 58 |
|
|
2019
Q2 | $605K | Sell |
13,349
-100
| -0.7% | -$4.66K | 0.26% | 77 |
|
|
2019
Q1 | $642K | Buy |
13,449
+330
| +3% | +$16.4K | 0.29% | 72 |
|
|
2018
Q4 | $682K | Buy |
13,119
+94
| +0.7% | +$5.05K | 0.34% | 64 |
|
|
2018
Q3 | $809K | Hold |
13,025
| – | – | 0.36% | 60 |
|
|
2018
Q2 | $721K | Sell |
13,025
-807
| -6% | -$43.6K | 0.35% | 63 |
|
|
2018
Q1 | $875K | Buy |
13,832
+110
| +0.8% | +$7.08K | 0.44% | 57 |
|
|
2017
Q4 | $841K | Sell |
13,722
-250
| -2% | -$15.6K | 0.41% | 60 |
|
|
2017
Q3 | $891K | Sell |
13,972
-608
| -4% | -$35.5K | 0.44% | 57 |
|
|
2017
Q2 | $812K | Hold |
14,580
| – | – | 0.42% | 61 |
|
|
2017
Q1 | $793K | Buy |
14,580
+600
| +4% | +$32.9K | 0.42% | 59 |
|
|
2016
Q4 | $817K | Buy |
13,980
+13,972
| +174,650% | +$764K | 0.43% | 59 |
|
|
2016
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 216 |
|
|
2016
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 211 |
|
|
2016
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 212 |
|
|
2015
Q4 | $1K | Buy |
+8
| New | +$529 | ﹤0.01% | 204 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
Alpha Omega Wealth Management's BMY Position: Q2 2026 in Review
Alpha Omega Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 0.75% in Q2 2026, selling an estimated $11.5K and leaving 26,593 shares worth $1.53M. The position accounts for 0.23% of the portfolio, ranked #104.
Alpha Omega Wealth Management first reported a position in BMY in Q4 2015 and has held it in 43 quarters since. The position peaked at $3.3M in Q2 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Alpha Omega Wealth Management held 26,593 shares of Bristol-Myers Squibb worth $1.53M as of Q2 2026.
- Alpha Omega Wealth Management sold 200 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5K.
- Bristol-Myers Squibb made up 0.23% of Alpha Omega Wealth Management's portfolio in Q2 2026, its #104 holding.
- Alpha Omega Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 43 quarters since.
- Alpha Omega Wealth Management's Bristol-Myers Squibb position peaked at $3.3M in Q2 2022.
- 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Alpha Omega Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.